The short version of pentadecapeptide fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2025-09-16. Anything still debated is marked as such rather than presented as settled.
Proposed mechanisms include interaction with the nitric oxide system, modulation of growth factor signaling, and effects on blood vessel formation. None of these has been established as the primary mode of action, and some proposed pathways rest on indirect measurements. Whether the reported effects depend on a specific receptor has not been determined. Stability in gastric acid, unusual for a peptide of this size, is also reported in animal work, but the reason for it is not firmly established.
Published studies on BPC-157 are dominated by animal models. Commonly used endpoints include healing of surgically induced lesions in the stomach, tendon-to-bone attachment after transection, and recovery from experimentally induced vascular or intestinal damage. Many of these reports come from a small number of research groups, and the peptide is often described as acting across a wide range of tissue types. That breadth is itself a point of discussion, since one molecule influencing many unrelated systems is unusual.
Human data are far more limited than animal data. A small number of clinical reports exist, generally with few participants and without the randomization or blinding expected in later-phase trials. No large, independently replicated human trial has appeared in the indexed peer-reviewed literature. Statements about effects in people therefore rest on extrapolation from animal work rather than on direct evidence, and the strength of that extrapolation remains an open question rather than a settled matter.
Analytical results depend on the column, gradient, and detector wavelength chosen by the laboratory, so purity values from different sources are not always directly comparable. Water content, counterion form, and residual trifluoroacetate affect both mass and purity calculations. Microbiological and endotoxin testing are separate from chemical purity and are not covered by a standard chromatographic run. Buyers evaluating a material typically request the full method description rather than a single purity figure.
Lyophilized peptide powder is generally stored at minus twenty degrees Celsius or lower and kept away from light and moisture. Under these conditions degradation is slow, and sealed vials remain stable for extended periods. Once dissolved, the material is less stable, particularly in aqueous buffers near neutral pH, where hydrolysis and oxidation proceed faster. Solutions are usually kept cold and used within days to weeks. Repeated freeze-thaw cycles are avoided because they encourage aggregation.
| Property | Value | Notes |
|---|---|---|
| Study species | Rodents, mainly rats | Most reports use surgically induced injury models |
| Typical administration route | Subcutaneous or intraperitoneal injection | Routes differ between reports, which complicates comparison |
| Human trial evidence | Limited, small-scale reports | No large randomized trial in indexed journals |
| Reported outcome categories | Mucosal healing, tendon repair, vascular recovery | Endpoints are not standardized across studies |
| Mechanism status | Not established | Proposed pathways lack direct confirmation |
Published work on BPC-157 spans several decades and covers a wide range of experimental models. Much of the early literature reports outcomes in animal studies involving induced injury to the gastrointestinal tract, tendons, and other tissues. The volume of preclinical reports is large, while controlled human trials remain scarce. This imbalance is a recurring point of discussion, because animal findings do not automatically translate into human effects. Reviews often note that study designs differ substantially across laboratories.
Interest in the peptide has grown through online communities that discuss self-administered use, which sits outside formal research settings. Regulatory status varies by country, and in many jurisdictions the compound is not approved as a therapeutic product. Questions about optimal routes of administration, long-term effects, and dose-response relationships remain open. Published pharmacokinetic data in humans are limited, and much of what circulates in popular discussion is extrapolated from animal work rather than measured directly in people.
BPC-157 is a synthetic peptide built from fifteen amino acids, referred to in the literature as a pentadecapeptide. Its sequence was derived from a larger protein found in human gastric juice, commonly called body protection compound. Researchers first described the fragment in the early 1990s and named it after the parent protein plus a numeric identifier. The peptide does not correspond to a single marketed medicine; it is primarily a laboratory research material. Suppliers distribute it as a lyophilized powder intended for experimental use.
Several mechanisms have been proposed to explain the activity observed in animal models. The most frequently cited involve signaling through vascular endothelial growth factor receptor 2 and modulation of the nitric oxide system. Researchers have also described interactions with protective pathways in the gut lining. These proposed mechanisms appear in the literature as hypotheses supported by preclinical observations, not as confirmed pathways in humans. The precise way the peptide produces its reported effects, and whether those effects carry across species, remain areas of active and unresolved investigation.
BPC-157 is a synthetic pentadecapeptide, meaning it consists of fifteen amino acids joined in a single chain. Its sequence is Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val, a fragment corresponding to part of a larger protein found in human gastric juice. The peptide was first described in the 1990s by researchers in Zagreb who were studying gastric protective factors. It is not a naturally circulating hormone; it is a laboratory-made fragment derived from a stomach protein. The name is an abbreviation of body protection compound, with the number referring to the fragment's position in the source protein.
=== Toxicity === There are two aspects to the harmful effects of plutonium: radioactivity and heavy metal poisoning. Plutonium compounds are radioactive and accumulate in bone marrow. Contamination by plutonium oxide has resulted from nuclear disasters and radioactive incidents, including military nuclear accidents where nuclear weapons have burned. Studies of the effects of these smaller releases, as well as of the widespread radiation poisoning sickness and death following the atomic bombings of Hiroshima and Nagasaki, have provided considerable information regarding the dangers, symptoms and prognosis of radiation poisoning, which in the case of the Japanese survivors was largely unrelated to direct plutonium exposure. The decay of plutonium, releases three types of ionizing radiation: alpha (α), beta (β), and gamma (γ). Either acute or longer-term exposure carries a danger of serious health outcomes including radiation sickness, genetic damage, cancer, and death. The danger increases with the amount of exposure. α-radiation can travel only a short distance and cannot travel through the outer, dead layer of human skin. β-radiation can penetrate human skin, but cannot go all the way through the body. γ-radiation can go all the way through the body. Even though α radiation cannot penetrate the skin, ingested or inhaled plutonium does irradiate internal organs. α-particles generated by inhaled plutonium have been found to cause lung cancer in a cohort of European nuclear workers.
Pituitary adenylate cyclase-activating polypeptide, also known as PACAP, is a protein that in humans is encoded by the ADCYAP1 gene. PACAP is similar to vasoactive intestinal peptide. One of its effects is to stimulate enterochromaffin-like cells. It binds to the vasoactive intestinal peptide receptor and the PACAP receptor.
== References == Crowl, Philip A. (1995). The Pacific War: Campaign in the Marianas. United States Army in World War II. United States Army Center of Military History. ISBN 978-0-16-089915-7. LCCN 60-60000. Archived from the original on 21 July 2022. Retrieved 10 February 2017. Hoyt, Edwin Palmer (1986). Japan's War: The Great Pacific Conflict, 1853 to 1952. New York: McGraw-Hill. ISBN 0-07-030612-5. Morison, Samuel Eliot (1953). New Guinea and the Marianas, March 1944 – August 1944. History of United States Naval Operations in World War II. Vol. VIII. Little, Brown and Company. Polmar, Norman (2008). Aircraft Carriers: A History of Carrier Aviation and Its Influence on World Events, 1946–2006. Vol. II. Washington, D.C.: Potomac Books. pp. 377–400. ISBN 978-1-57488-665-8. Archived from the original on 21 July 2022. Retrieved 1 June 2014. Potter, E. B. (1990). Admiral Arleigh Burke. Naval Institute Press. ISBN 978-1-59114-692-6. Roscoe, Theodore (1949). Pig Boats. New York: Bantam Books. ISBN 978-0-553-13040-4. {{cite book}}: ISBN / Date incompatibility (help) Shaw, Henry I. Jr.; Nalty, Bernard C.; Turnbladh, Edwin T. (1966). "Strategic Victory in the Marianas Liberation of Guam; Capture of Saipan and Tinian". Central Pacific Drive (PDF). History of U.S. Marine Corps Operations in World War II. Vol. III. Historical Branch, G-3 Division, Headquarters, U.S. Marine Corps. Archived (PDF) from the original on 26 January 2021. Retrieved 25 November 2020. Shores, Christopher (1985). Duel for the Sky: Ten Crucial Battles of World War II. London: Grub Street. ISBN 978-0-7137-1601-6.
Halliwell B; Gutteridge JM (1984). "Oxygen toxicity, oxygen radicals, transition metals and disease". Biochemical Journal. 219 (1): 1–14. doi:10.1042/bj2190001. PMC 1153442. PMID 6326753. Murphy MP, Bayir H, Belousov V, Chang CJ, Davies KJ, Davies MJ, Dick TP, Finkel T, Forman HJ, Gems D, Janssen-Heininger Y, Kagan VE, Kalyanaraman B, Larsson NG, Mile GL, Nyström T, Poulsen HE, Radi R, Remmen HV, Schumacker PT, Thornalley PJ, Toyokuni S, Winterbourn CC, Yin H, Halliwell B. (2022) Guidelines for measuring reactive oxygen species and oxidative damage in cells and in vivo. Nature Metabolism 4, 651–662. Research articles
== Impact == Following the release of The Beauty, renewed interest emerged in the original comic, The Beauty #1, published by Image Comics. The issue appeared on Key Collector Comics' "Trending 20" list and was featured by the YouTube channel ComicTom101 in its "Hot 10" rankings over multiple consecutive weeks. Secondary market activity increased, with raw copies reportedly selling for as much as $64 on eBay, while higher-grade and later printings recorded correspondingly higher prices. During the week of the series' premiere, The Beauty #1 placed No. 7 among trending comics in the United States and was reported to have reached a sale price of $199 for a CGC 9.8 copy, with a near-mint fair market value of $53 for raw copies.
Sources: en.wikipedia.org
=== Mosquitoes === Mosquitoes were found to be attracted to skin odors of individuals infected by malaria parasites (Plasmodium falciparum gametocytes). The attraction of uninfected mosquitoes was two to three times higher in children infected with gametocytes, and the attraction resumed to baseline following successful antimalarial treatments. Further investigation found a consistent effect of malaria on skin VOC profiles among populations with high malaria rates, where the infected showed a higher level of aldehydes heptanal, octanal, and nonanal, and notable distinguishable effects of asymptomatic and symptomatic infections.
At least one person has been killed by carbon dioxide gas subliming off dry ice in coolers placed in a car. In 2020, three people were killed at a party in Moscow after 25 kg of dry ice was dumped in a pool; carbon dioxide is heavier than air, and so can linger near the ground, just above water level.
Dye-sub printing is a digital printing technology using full color artwork that works with polyester and polymer-coated substrates. Also referred to as digital sublimation, the process is commonly used for decorating apparel, signs and banners, as well as novelty items such as cell phone covers, plaques, coffee mugs, and other items with sublimation-friendly surfaces. The process uses the science of sublimation, in which heat and pressure are applied to a solid, turning it into a gas through an endothermic reaction without passing through the liquid phase. In sublimation printing, unique sublimation dyes are transferred to sheets of "transfer" paper via liquid gel ink through a piezoelectric print head. The ink is deposited on these high-release inkjet papers, which are used for the next step of the sublimation printing process. After the digital design is printed onto sublimation transfer sheets, it is placed on a heat press along with the substrate to be sublimated. In order to transfer the image from the paper to the substrate, it requires a heat press process that is a combination of time, temperature and pressure. The heat press applies this special combination, which can change depending on the substrate, to "transfer" the sublimation dyes at the molecular level into the substrate. The most common dyes used for sublimation activate at 175 °C. However, a range of 195 °C to 215 °C is normally recommended for optimal color. The result of the sublimation process is a nearly permanent, high resolution, full color print.
== Creation and different nominations == 1943 - 1947 : creation of the 9th Colonial Infantry Division (French: 9e Division d'Infanterie Coloniale, 9e D.I.C) 1963 - 1976 : designated as 9th Brigade (French: 9e Brigade, 9eB) 1976 - 1999 : designated as 9th Marine Infantry Division (French: 9e Division d'Infanterie de Marine, 9e D.I.Ma) 1999 - 2013 : designated as 9th Light Armoured Marine Brigade (French: 9e Brigade Légère Blindée de Marine, 9e B.L.B.Ma) 2013–present : designated as 9th Marine Infantry Brigade (French: 9e Brigade d'Infanterie de Marine, 9e B.I.Ma)
Sources: en.wikipedia.org
It is not authorized as a medicine in the United States or the European Union. Regulatory treatment varies by jurisdiction, and in several places it is handled as a research chemical. Therapeutic claims are not supported by large human trials.
Human evidence is sparse and comes from small reports rather than large trials. Sample sizes are generally too small to support firm conclusions. The published record does not contain an independently replicated randomized trial.
Several pathways have been proposed, including effects on nitric oxide signaling and vessel formation. Direct confirmation of a primary molecular target is lacking. Some findings rest on indirect measurements, which leaves the mechanism an open question.
Bacteriostatic water or sterile saline is commonly used to dissolve the powder. The choice of solvent affects stability and preservation. Aqueous solutions are kept refrigerated and are not intended for long-term storage.